Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. - Wikidata - wikimedia - TriplyDB

Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.

Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.

http://www.wikidata.org/entity/Q33371495

about

Atypical hemolytic uremic syndrome The CD46-Jagged1 interaction is critical for human TH1 immunity Hemolytic uremic syndrome: new developments in pathogenesis and treatment Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome Pathogenesis of thrombotic microangiopathies Complement regulator CD46: genetic variants and disease associations Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort Gene conversion causing human inherited disease: evidence for involvement of non-B-DNA-forming sequences and recombination-promoting motifs in DNA breakage and repair.Complement factor h gene abnormalities in haemolytic uraemic syndrome: from point mutations to hybrid gene Identification of common genetic variation that modulates alternative splicing Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome Recurrence of HUS due to CD46/MCP mutation after renal transplantation: a role for endothelial microchimerism.Complement inhibitor eculizumab in atypical hemolytic uremic syndrome.Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations.Genetics and complement in atypical HUS.aHUS caused by complement dysregulation: new therapies on the horizon.Variant-specific quantification of factor H in plasma identifies null alleles associated with atypical hemolytic uremic syndrome.Disease-associated N-terminal complement factor H mutations perturb cofactor and decay-accelerating activities.Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP.Thrombotic microangiopathy mimicking membranoproliferative glomerulonephritis.Age-related penetrance of hereditary atypical hemolytic uremic syndrome.Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon?Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics STEC-HUS, atypical HUS and TTP are all diseases of complement activation.Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.Familial atypical hemolytic uremic syndrome: a review of its genetic and clinical aspects.Thrombocytopenia is not mandatory to diagnose haemolytic and uremic syndrome.Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.Changing strategies for organ transplantation in atypical haemolytic uraemic syndrome: a tertiary case series.Successful long-term outcome after renal transplantation in a patient with atypical haemolytic uremic syndrome with combined membrane cofactor protein CD46 and complement factor I mutations.Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations.Complement therapy in atypical haemolytic uraemic syndrome (aHUS).Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome.Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie University Hospital: concentration of C3 p.I1157T mutation.Atypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literature An international consensus approach to the management of atypical hemolytic uremic syndrome in children.Complement Regulates Nutrient Influx and Metabolic Reprogramming during Th1 Cell Responses Incomplete penetrance of CD46 mutation causing familial atypical hemolytic uremic syndrome.The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies

P2860

Q21202864-AB74514A-E381-485B-B3F0-F5EA2827796E Q24301407-A634C96D-E407-4F7E-B7A1-9AD386534932 Q24613517-8F2A0BB8-6804-4193-9BC5-73802778C665 Q24650823-FE6511D4-9561-40B3-9D24-A58C1EDA7C19 Q24658043-DE97BEF5-1770-4F07-83A1-E7553BE33E28 Q28263110-09B09366-0B7E-40B3-8056-1884A715F50A Q28741729-F035F855-D51F-494D-B370-54A7D804400F Q30491768-FFE290CB-F088-4953-9616-EFD8D02A8C94 Q33262235-FFAE5680-CCAE-47CD-8795-E2C28767DE0A Q33287883-74A87216-F7E0-41A8-B2BC-8102CD08D09A Q33372897-3DEB7AF0-CC84-4B92-A2B9-C257BAF99B7E Q33375818-BF94C737-CA2E-4D3F-B25E-D58DE8DE2988 Q33385154-E4878658-2800-4F4D-B58F-D1EC7BEF5171 Q33388474-3597DE42-835B-4240-AFF7-3854DBF36B1F Q33389945-F8D81409-8486-4132-97C8-768432219C68 Q33390198-A0516F25-AFB1-48DA-91F5-E0DB2A20EF18 Q33391370-25C76CDB-C668-41D9-8E12-2A1B2690068A Q33393852-AFC725A5-C5EE-4A9A-8C69-CAF8821A9F5B Q33395944-15DCCD4E-2C02-4243-9E64-2D858D87096C Q33396467-304F1C6A-24FD-4FFE-8518-3FAA07E89F4B Q33397115-7BEC1AFE-CF57-4D9C-8F80-3C819F600E56 Q33399052-A65F3C89-9820-4DFD-B957-406D627832C1 Q33400211-54B0206D-305F-43AA-979D-3F689F53399E Q33403359-64B97370-B558-4951-877F-7970F0F26E5C Q33404847-D85E4F9D-CBA8-487D-87D7-5DBAA9A5A960 Q33404888-571B24F8-4CC0-45DF-943E-D933BEC35D9C Q33405163-4CDE07C8-FF9C-4923-8D20-A58149CDC056 Q33405522-BB29E426-A9D8-4B0B-8C55-2D77746F4FCD Q33406025-5EA837BF-32FB-47C2-A511-FDAA67AAE0A9 Q33406251-41922F82-095C-4F53-83FD-F16DD4BE1047 Q33406584-4C022FEF-A9B1-4976-B8EA-1EE1FA9C0FA5 Q33408171-F355815A-0839-4D3F-BF89-B82707C0B41C Q33408733-55FDB0EF-8F9E-49DE-8321-0D19CAD5669F Q33410276-831062F0-6317-4A86-8AE0-ECF8936A45C6 Q33417165-40142563-548E-4338-B094-01C124611FBD Q33419812-E17FC974-142A-42C3-9DC2-D6158E31D3A1 Q33421861-4648EB7B-A1C1-49DA-8045-1BB19C595563 Q33423703-70EC62A8-AF43-4FBA-A5F0-AF149475629E Q33425435-804C87B5-7795-4274-9920-243BB970E7E3 Q33427495-DF4E1002-73FA-4FE6-979E-069F22F12228

P2860

Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.

http://www.wikidata.org/entity/Q33371495

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Genetic and functional analyse ...... cal hemolytic uremic syndrome.

@ast

Genetic and functional analyse ...... cal hemolytic uremic syndrome.

@en

type

label

Genetic and functional analyse ...... cal hemolytic uremic syndrome.

@ast

Genetic and functional analyse ...... cal hemolytic uremic syndrome.

@en

prefLabel

Genetic and functional analyse ...... cal hemolytic uremic syndrome.

@ast

Genetic and functional analyse ...... cal hemolytic uremic syndrome.

@en

P1433

Q33371495-EF6EDDCB-D3AB-4834-9498-738A1005C35F

P1476

Q33371495-5D36ADF1-37AA-4A71-BE5B-6C359011EF97

P2093

Q33371495-02F49983-F492-4556-AFF3-B9AD0D33A389

Q33371495-0BE0D6FF-4995-4272-96FE-3B38048CE195

Q33371495-0ECF6FA4-D203-4791-AFCE-679969CD23EC

Q33371495-26F4CB4E-1105-4810-9D29-2B5428E3155C

Q33371495-3EDABA13-A41F-43BC-9EC3-439839D87223

Q33371495-79F9E4B1-55BB-4F3E-AA2A-A6F98A12D940

Q33371495-8E2C19E7-44AC-4D31-9765-E002711299E6

Q33371495-E4C377A4-01FC-46E9-85A9-DD07E5E797BF

Q33371495-E720C459-60FB-408F-9582-EF4E2307CD5E

Q33371495-EEC42084-9E01-4765-86B2-7D048AAC42A7

P304

Q33371495-8BA688BF-B692-4C57-8961-F9C77B0CF47E

P31

Q33371495-984AC764-12E9-430F-8DEE-7207B5870FCA

P356

Q33371495-BF062C24-896D-4BE3-A9AC-1CD4BFC51B41

P433

Q33371495-208A2CCC-3DCA-4B53-9DAE-421E1620D674

P478

Q33371495-51BF3047-C125-432D-BBEE-0E8E6D6B0B8A

P50

Q33371495-0EF9DBC0-2DF2-4D28-9657-35B33F862996

Q33371495-10D94C64-CDCE-4107-8E63-22B1A0CF71C6

Q33371495-51562C01-D2A8-4BA9-A6DF-1A65C8A299FF

Q33371495-C3BF7FEF-E7CA-4B1D-800B-8F4745975A8C

P577

Q33371495-A06010D9-876B-4272-8ADF-F4668309C090

P5875

Q33371495-501CE9D0-2FC1-4C0C-8B94-BD59BAE549D7

P698

Q33371495-8B37A59E-FF66-4786-82C3-8A0B9D06A8EE

P356

P1433

Journal of the American Society of Nephrology

P1476

Genetic and functional analyse ...... cal hemolytic uremic syndrome.

@en

P2093

Chantal Loirat

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Moulton

http://www.w3.org/2001/XMLSchema#string

Genevieve Guest

http://www.w3.org/2001/XMLSchema#string

Jacques Blouin

http://www.w3.org/2001/XMLSchema#string

Jacques Pourrat

http://www.w3.org/2001/XMLSchema#string

John P Atkinson

http://www.w3.org/2001/XMLSchema#string

Maud Francois

http://www.w3.org/2001/XMLSchema#string

Nadia Arzouk

http://www.w3.org/2001/XMLSchema#string

Roland Seligman

http://www.w3.org/2001/XMLSchema#string

Roxanna Cleper

http://www.w3.org/2001/XMLSchema#string

P304

2017-2025

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2005101051

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Wolf Hervé Fridman

Marie-Agnès Dragon-Durey

P577

2006-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7020298

http://www.w3.org/2001/XMLSchema#string

P698

16762990

http://www.w3.org/2001/XMLSchema#string